{
    "Trade/Device Name(s)": [
        "BD BBL Sensi-disc Ceftazidime Avibactam (30/20ug)",
        "BD BBL Sensi-Disc Ceftazidime avibactam (30/20\u03bcg), Antimicrobial Susceptibility Test Discs"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K152516",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JTN"
    ],
    "Summary Letter Date": "September 1, 2015",
    "Summary Letter Received Date": "September 3, 2015",
    "Submission Date": "September 1, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.1620"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test disc"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ceftazidime avibactam",
        "Escherichia coli",
        "Enterobacter cloacae",
        "Klebsiella pneumoniae",
        "Klebsiella oxytoca",
        "Proteus mirabilis",
        "Providencia stuartii",
        "Pseudomonas aeruginosa",
        "Citrobacter freundii",
        "Citrobacter koseri",
        "Enterobacter aerogenes",
        "Proteus spp.",
        "Morganella morganii",
        "Providencia rettgeri",
        "Serratia marcescens"
    ],
    "Specimen Type(s)": [
        "Pure bacterial culture isolates"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Mueller Hinton Agar plates",
        "Haemophilus Test Medium Agar",
        "Mueller Hinton Agar with 5% Sheep Blood (for Streptococcus species)"
    ],
    "Method(s)/Technology(ies)": [
        "Agar diffusion",
        "Disk diffusion"
    ],
    "Methodologies": [
        "Semi-quantitative in vitro susceptibility testing",
        "Measurement of inhibition zones"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Disk",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for BD BBL Sensi-disc Ceftazidime Avibactam (30/20ug) antimicrobial susceptibility test disks for agar diffusion susceptibility testing of gram-negative bacteria.",
    "Indications for Use Summary": "Used for in vitro agar diffusion susceptibility testing to determine bacterial susceptibility to Ceftazidime avibactam for strains associated with complicated intra-abdominal and urinary tract infections.",
    "fda_folder": "Microbiology"
}